110 Results for "

sEH

" in MedChemExpress (MCE) Product Catalog:
Products (110)

110 Results for "sEH" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-101294
CAS No.: 1222780-33-7
Purity:  99.10%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

TPPU is a soluble epoxide hydrolase (sEH) inhibitor with IC50 values of 37 and 3.7 nM for monkey and human sEH, respectively.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108570
CAS No.: 479413-70-2
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

AUDA (compound 43) is a potent soluble epoxide hydrolase (sEH) inhibitor with IC50s of 18 and 69 nM for the mouse and human sEH, respectively . AUDA has anti-inflammatory activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19644
CAS No.: 1142090-23-0
Synonyms: GSK 2256294
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

GSK2256294A (GSK 2256294) is a selective and orally active inhibitor of soluble epoxide hydrolase (sEH). GSK2256294A inhibits recombinant human sEH, rat sEH orthologs and murine sEH orthologs with IC50s of 27, 61 and 189 pM, respectively. GSK2256294A can be used for the research of chronic obstructive pulmonary disease (COPD) and cardiovascular disease .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113974
CAS No.: 885012-33-9
Purity:  98.16%
Synonyms: t-AUCB
Target:  

Epoxide Hydrolase

Research Areas:  

Cancer

trans-AUCB (t-AUCB) is a potent, orally active and selective soluble epoxide hydrolase (sEH) inhibitor with IC50s of 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively. trans-AUCB has anti-glioma activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128171
CAS No.: 724453-98-9
Purity:  99.67%
Target:  

FLAP Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

Diflapolin is a highly active dual 5-lipoxygenase-activating protein (FLAP)/soluble epoxide hydrolase (sEH) inhibitor with marked anti-inflammatory efficacy and high target selectivity. Diflapolin inhibits 5-LOX product formation in intact human monocytes and neutrophils with IC50s?of? 30 and 170?nM, respectively, and suppressed the activity of isolated sEH (IC50=20?nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135653
CAS No.: 1809885-32-2
Purity:  98.13%
Synonyms: BPN-19186
Target:  

Epoxide Hydrolase

Research Areas:  

Neurological Disease

EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121538
CAS No.: 479413-68-8
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase PPAR

Research Areas:  

Cardiovascular Disease

CUDA is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC50s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively . CUDA selectively increases peroxisome proliferator-activated receptor (PPAR) alpha activity. CUDA may be valuable for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111151
CAS No.: 913548-29-5
Purity:  99.69%
Synonyms: APAU
AR9281 (APAU) is a potent, selective and orally active soluble epoxide hydrolase (s-EH) inhibitor. AR-9281 can inhibits human sEH (HsEH) and murine sEH (MsEH) with IC50 values of 13.8 nM and 1.7 nM, respectively. AR9281 can be used for the research of inflammation, hypertension and type 2 diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124063
CAS No.: 940954-41-6
Purity:  98.01%
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

BI-1935, a chemical probe, is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0805A
CAS No.: 18649-93-9
Category:  

Triterpenes 500 - Internal Server Error | MedChemExpress

Oops!

Sorry, Something went wrong on our server.
Our team has been notified and is working to fix the issue.